{
    "complex": false,
    "classification": "non-complex",
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [],
    "supporting_data": "The VanEck Bionic Engineering UCITS ETF is a physically replicated ETF that directly invests in the underlying equity securities of its benchmark index. While the KIID mentions the potential use of derivatives (including swaps, futures, and options) for replication or efficient portfolio management, the factsheet explicitly states that the fund uses 'Physical (Full Replication)' as its product structure. The fund does not employ leverage, inverse strategies, or synthetic replication. The risk profile is high (rated 7), but this is due to sector concentration and equity market risks rather than structural complexity. The fund is UCITS-compliant, which imposes additional investor protection and transparency requirements. The absence of capital protection features, structured products, or illiquid assets further supports a non-complex classification.",
    "confidence": 90,
    "counter_argument": "The KIID mentions the potential use of derivatives, which could suggest complexity. However, the factsheet clarifies that the fund primarily uses physical replication, and any derivative usage appears to be for efficient portfolio management (EPM) rather than as a core strategy. The fund's transparency, liquidity, and straightforward investment approach outweigh the derivative permissions in its mandate.",
    "risk_level": "high",
    "risk_explanation": "The high risk level (7) is attributed to equity market risk and sector concentration rather than structural complexity. The fund's performance is directly tied to the underlying securities, and there are no complex payoff structures or embedded derivatives that would make it difficult for retail investors to understand."
}